ACE2 and obesity due to melanocortin 4 receptor deficiency: In addition to this, since both ACE2 deficiency and obesity have been characterized as an accelerated aging phenotype [49], both conditions together could explain the reason why some of the beneficial effects observed in ACE2-/y disappear in the 12-month age.